Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Asthma Chronic
Interventions
OTHER

ICS dose reduction

"If control of symptoms is maintained (evaluation based on clinical symptoms solely), every 3 months the dose of ICS is halved according to GINA guidelines, until the control is lost or the lowest daily dose is reached (200 mcg, calculated as budesonide equivalent).~In the case of loss of asthma control, beta-mimetic will be administered (temporarily) and return to the chronic administration of the previous, twice higher dose of ICS is restored (or further increase of treatment). In severe exacerbations, inclusion of oral steroids will be considered."

Trial Locations (1)

38-600

The Regional Public Hospital in Lesko, Poland, Lesko

All Listed Sponsors
collaborator

University of Rzeszow

OTHER

collaborator

The Regional Public Hospital in Lesko, Poland

OTHER

lead

National Institute for Tuberculosis and Lung Diseases, Poland

OTHER

NCT03788057 - Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma | Biotech Hunter | Biotech Hunter